Search Within

Patrick Dale Hilden

Formats
  1. Meeting Abstract (68)
  2. Journal Article (40)
Groups
  1. Center for Hematologic Malignancies (96)
  2. Department of Medicine (94)
  3. Hematologic Malignancies, Division of (89)
  4. Bone Marrow Transplant (78)
  5. Survivorship Research (64)
  6. Biostatistics Service (63)

More Groups

People
  1. Sergio Giralt (69)
  2. Miguel-Angel Perales (60)
  3. Molly Maloy (47)
  4. Ann Jakubowski (46)
  5. Esperanza Papadopoulos (44)
  6. Hugo Castro-Malaspina (44)

More People

Years
  1. 2021 (3)
  2. 2020 (5)
  3. 2019 (10)
  4. 2018 (21)
  5. 2017 (16)
  6. 2016 (18)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (42)
  2. Blood (30)
  3. Bone Marrow Transplantation (6)
  4. Journal of Clinical Oncology (4)
  5. International Journal of Radiation Oncology, Biology, Physics (3)
  6. Journal of Thoracic Oncology (3)

More Publications

Publishers
  1. Elsevier Inc. (48)
  2. American Society of Hematology (32)
  3. Nature Publishing Group (7)
  4. American Society of Clinical Oncology (5)
  5. John Wiley & Sons (3)
  6. Elsevier Ltd (2)

More Publishers

Results (108)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adverse cytogenetic abnormalities at diagnosis are the most important predictor of relapse post T cell depleted (TCD) allogeneic hematopoietic stem cell transplantation in patients with advanced myelodysplastic syndrome (MDS)
    Meeting Abstract

    Tamari, R.; Jakubowski, A. A.; Papadopoulos, E. B.; Giralt, S. A.; Goldberg, J. D.; Ponce, D. M.; Sauter, C. S.; Hilden, P.; Devlin, S.; Young, J. W.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • The hematopoietic cell transplant-co-morbidity index (HCT-CI) predicts outcomes after T cell depleted (TCD) allogeneic HCT for AML and MDS
    Meeting Abstract

    Ratan, R.; Ceberio, I.; Hilden, P.; Devlin, S. M.; Malloy, M. A.; Barker, J. N.; Castro-Malaspina, H.; Jakubowski, A. A.; Koehne, G.; Papadopoulos, E. B.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • High day 28 ST2 biomarker levels predict severe day 100 acute graft-versus-host disease and day 180 transplant-related mortality after double-unit cord blood transplantation
    Meeting Abstract

    Ponce, D. M.; Hilden, P.; Mumaw, C.; Devlin, S.; Lubin, M. N.; Evans, K. L.; Prockop, S.; Scaradavou, A.; Kernan, N. A.; Giralt, S. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Outcomes in patients with acute lymphoblastic leukemia in first or second complete remission receiving ex-vivo T-cell depleted or unmodified allografts: Comparison of results at two institutions
    Meeting Abstract

    Hobbs, G. S.; Hilden, P.; Hamdi, A.; Goldberg, J. D.; Poon, M.; Ledesma, C.; Devlin, S.; Rondon, G.; Papadopoulos, E. B.; Jakubowski, A. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • High-dose cytarabine monotherapy versus intermediate or high-dose cytarabine in combination with other agents as second-line salvage therapy In patients with acute myeloid leukemia who did not respond to initial induction therapy
    Meeting Abstract

    Dang, T. O. T.; Hilden, P.; Devlin, S. M.; Rampal, R. K.; Levine, R. L.; Berman, E.; Klimek, V. M.; Adel, N. G.; Tallman, M. S.
    Blood (2013)

    Fulltext@MSK | Save
  • T-cell depleted (TCD) hematopoietic stem cell transplantation (HCT) for adult patients with acute myelogenous leukemia (AML) In first and second remission: Long-term disease free survival (DFS) with a significantly reduced risk of graft-versus-host disease (GvHD)
    Meeting Abstract

    Ceberio, I.; Hilden, P.; Devlin, S. M.; Maloy, M.; Goldberg, J. D.; Perales, M. A.; Barker, J. N.; Castro-Malaspina, H.; Koehne, G.; Ponce, D. M.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Tumor expression of TTF1 is associated with a doubling of overall survival in patients with advanced lung adenocarcinomas
    Meeting Abstract

    Hellmann, M. D.; Hilden, P. D.; Sima, C. S.; Kris, M. G.; Rekhtman, N.; Chaft, J. E.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • "Intention-to-treat" outcomes of sequential patients with stage IIIA lung adenocarcinomas treated with neoadjuvant chemotherapy with intent of surgical resection
    Meeting Abstract

    Hellmann, M. D.; Chaft, J. E.; Hilden, P. D.; Rusch, V. W.; Kris, M. G.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save